• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • GPs

GP Profile: BGF to deploy GBP 500m-plus per year for minority growth deals with entrepreneurs

GP Profile: BGF to deploy GBP 500m-plus per year for minority growth deals with entrepreneurs
Andy Gregory, BGF
  • Ero Partsakoulaki
  • 23 March 2023
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

UK- and Ireland-based growth investor BGF expects its established minority investment strategy to retain its relevance amid the current economic downturn, and is continuing to review potential investment and exit opportunities, CEO Andy Gregory told Unquote.

As debt becomes less accessible to PE firms and businesses, equity providers with a longer-term view can provide solutions in uncertain times, he said. BGF tends not to raise debt to fund deals and deploys equity via its own balance sheet. It seeks to add value to its portfolio, mostly through ESG initiatives and providing sector expertise, he said.

Although a number of sponsors have launched minority investing funds in recent years, this strategy has underpinned the growth investor's approach since its formation in 2011. It aims to back entrepreneurs seeking flexible, value-adding capital.

The sponsor therefore expects its strategy to gain more traction as an attractive alternative to founders, filling a gap in the capital raising world, he said.

While its average check size has slightly increased, reaching GBP 6.9m last year, it is still "very much within" its original GBP 2m-GBP 10m target range, said Gregory.

The firm has increased its activity over the years, deploying "well over" GBP 1bn in the last 24 months, he said, noting that it expects to "at least maintain and hopefully grow" that level of activity. It invested GBP 443m in 2022 alone, completing 45 new deals in the UK and Ireland via its growth and early-stage strategies, as well as quoted investment teams.

Looking ahead, it expects to be deploying GBP 500m-plus per year on average, investing right through the cycle, he said.

Deploying through cycles
"We've done well because there is a genuine gap for us, even in a buoyant economy and a frothy M&A market, to add value and flexibility in addition to capital," he added. "PE firms often do minority investments with a majority mindset but our competition is a range of situations, from a modest debt raise and entrepreneurs choosing to do nothing, to majority stakes and trade sales."

The firm remains pragmatic in terms of the exit time scale for its portfolio. Although it is expecting overall exit activity in the market to come down in this environment, its exit pipeline remains positive, said Gregory.

The firm continues to receive a good level of inbound interest from strategic trade buyers and PE across sectors. Trade buyers make up the largest buyer pool for the GP, while its buy-and-build theme is seeing a reasonable amount of PE-backed trade interest, he added.

It exited 40 companies in 2022, with total investment returns of more than GBP 675m, a combined money multiple of 2x and an IRR of 22.5%.

The firm has owned minority stakes in UK-based online pharmacist Pharmacy2U and UK-based paint supplier to the automotive industry Paintbox since 2016, while holding a stake in UK-based energy provider STATS Group since 2012.

For the time being, BGF's investment committee is exploring a broad range of targets in sectors experiencing tailwinds, such as technology, tech-related healthcare, healthcare-related life sciences and cleantech. It is also considering strong businesses in "perhaps some of the less obvious sectors," he said. BGF is open to invest in sectors with uncertainty in the short term, as it is largely taking into account a company's capitalisation levels, overall positioning and growth, he added.

Diverse strategies
Alongside its growth investment strategy, BGF plans to invest GBP 300m in early-stage and fast-growth businesses over the next five years.

The strategy is primarily focussed on life sciences and cleantech, with elements of deep tech, said Gregory. Having invested in 500 companies in total over the last 12 years, the firm aims to leverage its sector expertise to support early-stage businesses.

The GP also launched BGF Foundation last year, with a commitment of GBP 1.5m from BGF and the portfolio over the next three years. It will provide funding and practical support to help small and mid-sized charities that are focused on alleviating social disadvantage to scale up their impact across the UK. The firm sees the strategy as complementary to its main growth investing approach but with a broader purpose, said Gregory.

It is looking to deploy that capital across the UK in areas which BGF has a presence via its 16 branches. Its regional network enables it to target businesses directly, so its pipeline is largely formed through its own origination efforts, he said. Its due diligence often benefits from expertise sourced via its talent network.

Continuing to bolster its team and global network, BGF is committed to supporting women-led businesses, whilst increasing gender diversity internally. Women accounted for 69% of its total staff hires last year and 57% of the hires for its investment team, he said.

[Editor's note: Subsequent to publication, the article was amended to clarify that BGF is a UK- and Ireland-based firm.]

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • GPs
  • Healthcare
  • Technology
  • Consumer
  • Support services
  • UK / Ireland
  • BGF (Business Growth Fund)
  • United Kingdom
  • Ireland
  • In Profile

More on GPs

IPO offers CVC chance to become multi-asset consolidator
IPO offers CVC chance to become multi-asset consolidator

Potential IPO also offers monetisation solution for founders and GP stakes investor Blue Owl

  • GPs
  • 25 August 2023
VC Profile: Possible Ventures lines up frontier tech deals halfway through fresh EUR 60m fundraise
VC Profile: Possible Ventures lines up frontier tech deals halfway through fresh EUR 60m fundraise

Germany-based pre-seed investor is set to hold a first close for its third fund in mid-September

  • GPs
  • 25 August 2023
GP Profile: Apheon builds on family roots, mulls exits and reinvestment opportunities
GP Profile: Apheon builds on family roots, mulls exits and reinvestment opportunities

Belgian GP, formerly known as Ergon, to continue to target family- and entrepreneur-owned European businesses

  • GPs
  • 18 August 2023
Kudu to step up boutique GP stake deals in Europe
Kudu to step up boutique GP stake deals in Europe

MassMutual-backed investor aims to add more infrastructure and specialised equity GPs to its portfolio

  • GPs
  • 09 August 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013